Search results
Drug companies challenge Minnesota prescription discount law in federal court
MPR News· 1 day agoSeveral drug companies filed lawsuits in federal court this week challenging a Minnesota law...
AbbVie cuts 2024 profit forecast on R&D expenses
Reuters via Yahoo Finance Canada· 2 days ago(Reuters) -AbbVie lowered its 2024 adjusted profit forecast on Wednesday, citing $937 million in milestones, and research and development expenses...
News By Company | Zymeworks Inc. News on T-Net
T-Net British Columbia· 2 days agoZymeworks
Cerevel Sued Over Stock Sale to Bain Ahead of AbbVie Deal News
Bloomberg Law· 2 days agoBain Capital LP affiliates may have arranged to buy stock on the cheap when they knew Cerevel Therapeutics Holdings Inc. was set to be acquired by AbbVie Inc. for $8.7 billion, a newly filed lawsuit says.
Company News for Jul 3, 2024
Zacks via Yahoo Finance Canada· 2 days agoShares of Apple Inc. AAPL rose 1.6% on the continued mega-cap growth stock rally. iQIYI, Inc.’s IQ shares rose 1.4% on consumer discretionaries scoring a...
MedinCell And Two More Euronext Paris Growth Stocks With High Insider Ownership
Simply Wall St. via Yahoo Finance Canada· 2 days agoAs the French market navigates through a period of political uncertainty with upcoming elections,...
Novo Nordisk, Lilly must cut US prices of weight-loss drugs, Biden says
Reuters via Yahoo Canada News· 3 days ago(Reuters) -U.S. President Joe Biden and Senator Bernie Sanders called on Novo Nordisk and Eli Lilly...
With 72% ownership, AbbVie Inc. (NYSE:ABBV) boasts of strong institutional backing
Simply Wall St. via Yahoo Finance Canada· 3 days agoKey Insights Significantly high institutional ownership implies AbbVie's stock price is sensitive to...
Top Insider-Owned Growth Companies On Euronext Paris July 2024
Simply Wall St. via Yahoo Finance Canada· 3 days agoAmid a backdrop of heightened political uncertainty and fluctuating market indices, France's...
AbbVie (ABBV) Gets CHMP Nod for Lymphoma Drug's Expanded Use
Zacks via Yahoo Finance Canada· 4 days agoAbbVie (ABBV) is seeking approval for Tepkinly in the EU as a monotherapy for the treatment of adult...